Jazz Pharma to purchase GW Pharma for $7.2 billion; plans to aid cannabis based drug to portfolio

Jazz Pharmaceuticals said on Wednesday it had consented to purchase GW Pharmaceuticals in a $7.2 billion money and-stock arrangement which